Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: A population-based study in Ontario, Canada

Journal of Clinical Oncology

Volumn 30, Issue 15, 2012, Pages 1813-1821

  Cuffe, Sinead ^a   Booth, Christopher M ^c,d   Peng, Yingwei ^c   Darling, Gail E ^b   Li, Gavin ^c,d   Kong, Weidong ^c,d   Mackillop, William J ^c,d   Shepherd, Frances A ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL;

AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; FEMALE; HOSPITALIZATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MEDICAL RECORD LINKAGE; MULTIVARIATE ANALYSIS; ODDS RATIO; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONECTOMY; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863937504     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.3330     Document Type: Article

References (43)

1. Hayat MJ, Howlader N, Reichman ME, et al: Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20-37, 2007 (Pubitemid 46143500)
2. Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 27:2758-2765, 2009
3. Jemal A, Thun MJ, Ries LA, et al: Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100:1672-1694, 2008
4. Arias E, Rostron B, Tejada-Vera B: United States Life Tables, 2005, National Vital Statistics Reports. Hyattsville, MD, National Center for Health Statistics, 2010, pp 1-132
5. Hanagiri T, Muranaka H, Hashimoto M, et al: Results of surgical treatment of lung cancer in octogenarians. Lung Cancer 23:129-133, 1999 (Pubitemid 29123882)
6. Yamamoto K, Padilla Alarcón J, Calvo Medina V, et al: Surgical results of stage I nonsmall cell lung cancer: Comparison between elderly and younger patients. Eur J Cardiothorac Surg 23:21-25, 2003 (Pubitemid 35472091)
7. Sawada S, Komori E, Nogami N, et al: Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition. Chest 128:1557-1563, 2005 (Pubitemid 41324447)
8. Cerfolio RJ, Bryant AS: Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: A nested case-control study. Ann Thorac Surg 82:424-429, 2006; discussion 429-430
9. Sigel K, Bonomi M, Packer S, et al: Effect of age on survival of clinical stage I non-small-cell lung cancer. Ann Surg Oncol 16:1912-1917, 2009
10. Booth CM, Shepherd FA: Adjuvant chemotherapy for resected non-small cell lung cancer. J Thorac Oncol 1:180-187, 2006 (Pubitemid 47189141)
11. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004 (Pubitemid 38101630)
12. Winton T, Livingston R, Johnson D, et al: Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589-2597, 2005 (Pubitemid 41007845)
13. Douillard JY, Rosell R, De Lena M, et al: Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 7:719-727, 2006 (Pubitemid 44283661)
14. Pignon JP, Tribodet H, Scagliotti GV, et al: Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552-3559, 2008
15. NSCLC Meta-Analyses Collaborative Group, Arriagada R, Auperin A, et al: Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: Two metaanalyses of individual patient data. Lancet 375:1267-1277, 2010
16. Pepe C, Hasan B, Winton TL, et al: Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 25:1553-1561, 2007 (Pubitemid 46733082)
17. Früh M, Rolland E, Pignon JP, et al: Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. J Clin Oncol 26:3573-3581, 2008
18. Gridelli C, Shepherd FA: Chemotherapy for elderly patients with non-small cell lung cancer: A review of the evidence. Chest 128:947-957, 2005 (Pubitemid 41140531)
19. Lewis JH, Kilgore ML, Goldman DP, et al: Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21:1383-1389, 2003 (Pubitemid 46606420)
20. Vlahakes GJ: The value of phase 4 clinical testing. N Engl J Med 354:413-415, 2006
21. Avorn J: In defense of pharmacoepidemiology: Embracing the yin and yang of drug research. N Engl J Med 357:2219-2221, 2007
22. Winget M, Stanger J, Gao Z, et al: Predictors of surgery and consult with an oncologist for adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada. J Thorac Oncol 4:629-634, 2009
23. Kassam F, Shepherd FA, Johnston M, et al: Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. J Thorac Oncol 2:39-43, 2007 (Pubitemid 47163927)
24. Oxnard GR, Fidias P, Muzikansky A, et al: Non-small cell lung cancer in octogenarians: Treatment practices and preferences. J Thorac Oncol 2:1029-1035, 2007 (Pubitemid 350059579)
25. Wang J, Kuo YF, Freeman J, et al: Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer. Cancer 112:382-390, 2008
26. Owonikoko TK, Ragin CC, Belani CP, et al: Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 25:5570-5577, 2007
27. Madroszyk-Flandin A, Bagattini S, Goncalves A, et al: Lung cancer in elderly patients: A retrospective analysis of practice in a single institution. Crit Rev Oncol Hematol 64:43-48, 2007 (Pubitemid 47362736)
28. Bouchard N, Laberge F, Raby B, et al: Adjuvant chemotherapy in resected lung cancer: Twoyear experience in a university hospital. Can Respir J 15:270-274, 2008
29. Younis T, Al-Fayea T, Virik K, et al: Adjuvant chemotherapy uptake in non-small cell lung cancer. J Thorac Oncol 3:1272-1278, 2008
30. Booth CM, Shepherd FA, Peng Y, et al: Adoption of adjuvant chemotherapy for non-small-cell lung cancer: A population-based outcomes study. J Clin Oncol 28:3472-3478, 2010
31. Pisters KM, Evans WK, Azzoli CG, et al: Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 25:5506-5518, 2007 (Pubitemid 350232227)
32. Kirkpatrick HM, Aitelli CL, Qin H, et al: Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. Clin Colorectal Cancer 9:150-156, 2010
33. DeMichele A, Putt M, Zhang Y, et al: Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: Evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97:2150-2159, 2003 (Pubitemid 36444055)
34. Douillard JY, Tribodet H, Aubert D, et al: Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: Subgroup analysis of the Lung Adjuvant Cisplatin Evaluation. J Thorac Oncol 5:220-228, 2010
35. Strauss GM, Herndon JE 2nd, Maddaus MA, et al: Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26:5043-5051, 2008
36. Hotta K, Matsuo K, Ueoka H, et al: Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 22:3852-3859, 2004 (Pubitemid 41079865)
37. Jiang J, Liang X, Zhou X, et al: A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer 57:348-358, 2007 (Pubitemid 47285418)
38. Massard C, Tran Ba Loc P, Haddad V, et al: Use of adjuvant chemotherapy in non-small cell lung cancer in routine practice. J Thorac Oncol 4:1504-1510, 2009
39. Asmis TR, Ding K, Seymour L, et al: Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: A review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 26:54-59, 2008
40. Yazgan S, Gürsoy S, Yaldiz S, et al: Outcome of surgery for lung cancer in young and elderly patients. Surg Today 35:823-827, 2005 (Pubitemid 41374385)
41. Zuin A, Marulli G, Breda C, et al: Pneumonectomy for lung cancer over the age of 75 years: Is it worthwhile? Interact Cardiovasc Thorac Surg 10:931-935, 2010; discussion 935
42. Rivera C, Falcoz PE, Bernard A, et al: Surgical management and outcomes of elderly patients with early stage of non-small cell lung cancer: A nested case-control study. Chest 140:874-880, 2011
43. Gridelli C, Langer C, Maione P, et al: Lung cancer in the elderly. J Clin Oncol 25:1898-1907, 2007 (Pubitemid 46854424)